Mayo Clinic launches neutralizing antibody test to advance COVID-19 therapies

ROCHESTER, Minn. -- Mayo Clinic has launched a new SARS-CoV-2 neutralizing antibody test in support of the national Expanded Access Program for Convalescent Plasma and other critical research efforts to establish effective therapies and vaccines for COVID-19. The test will be available through Mayo Clinic Laboratories to select labs, blood banks, and biopharma clients in [...]
Source: Mayo Clinic Business News - Category: Pharmaceuticals Source Type: news